0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antibiotic Resistance Sales Market Report 2021
Published Date: June 2021
|
Report Code: QYRE-Auto-36S5219
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Antibiotic Resistance Sales Market Report 2021

Global Antibiotic Resistance Sales Market Report 2021

Code: QYRE-Auto-36S5219
Report
June 2021
146 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures

Antibiotic Resistance Market

Antibiotic are medicines that are used to prevent various bacterial infections and antibiotic resistance is the inability of a microorganism to withstand the effects of an antibiotic. It is a specific type of drug resistance. These bacteria may infect humans and animals body, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Hence, antibiotic resistance leads to higher medical costs and increased mortality. 

The global Antibiotic Resistance market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027. 

The global Antibiotic Resistance market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antibiotic Resistance market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. 

By Type

  • By Disease
  • By Pathogen

By Application

  • Oxazolidinones
  • Lipoglycopeptides
  • Tetracyclines
  • Cephalosporins
  • Combination therapies
  • Other

The Antibiotic Resistance market is analysed and market size information is provided by regions (countries). Segment by Application, the Antibiotic Resistance market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions. 

By Company

  • Allergan
  • AmpliPhi Biosciences
  • BioVersys GmbH
  • Macrolide Pharmaceuticals
  • Melinta Therapeutics
  • Merck
  • Nabriva Therapeutics
  • Nemesis Bioscience
  • Phage Technologies S.A
  • Tetraphase Pharmaceuticals
  • The Medicines Company
  • TPfizer
  • Westway Health
1 Antibiotic Resistance Market Overview
1.1 Antibiotic Resistance Product Scope
1.2 Antibiotic Resistance Segment by Type
1.2.1 Global Antibiotic Resistance Sales by Type (2016 & 2021 & 2027)
1.2.2
1.2.3
1.3 Antibiotic Resistance Segment by Application
1.3.1 Global Antibiotic Resistance Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Oxazolidinones
1.3.3 Lipoglycopeptides
1.3.4 Tetracyclines
1.3.5 Cephalosporins
1.3.6 Combination therapies
1.3.7 Other
1.4 Antibiotic Resistance Market Estimates and Forecasts (2016-2027)
1.4.1 Global Antibiotic Resistance Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Antibiotic Resistance Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Antibiotic Resistance Price Trends (2016-2027)
2 Antibiotic Resistance Estimates and Forecasts by Region
2.1 Global Antibiotic Resistance Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Antibiotic Resistance Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Antibiotic Resistance Sales Market Share by Region (2016-2021)
2.2.2 Global Antibiotic Resistance Revenue Market Share by Region (2016-2021)
2.3 Global Antibiotic Resistance Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Antibiotic Resistance Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Antibiotic Resistance Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Antibiotic Resistance Estimates and Projections (2016-2027)
2.4.2 Europe Antibiotic Resistance Estimates and Projections (2016-2027)
2.4.3 China Antibiotic Resistance Estimates and Projections (2016-2027)
2.4.4 Japan Antibiotic Resistance Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Antibiotic Resistance Estimates and Projections (2016-2027)
2.4.6 India Antibiotic Resistance Estimates and Projections (2016-2027)
3 Global Antibiotic Resistance Competition Landscape by Players
3.1 Global Top Antibiotic Resistance Players by Sales (2016-2021)
3.2 Global Top Antibiotic Resistance Players by Revenue (2016-2021)
3.3 Global Antibiotic Resistance Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibiotic Resistance as of 2020)
3.4 Global Antibiotic Resistance Average Price by Company (2016-2021)
3.5 Manufacturers Antibiotic Resistance Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Antibiotic Resistance Market Size by Type
4.1 Global Antibiotic Resistance Historic Market Review by Type (2016-2021)
4.1.1 Global Antibiotic Resistance Sales Market Share by Type (2016-2021)
4.1.2 Global Antibiotic Resistance Revenue Market Share by Type (2016-2021)
4.1.3 Global Antibiotic Resistance Price by Type (2016-2021)
4.2 Global Antibiotic Resistance Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Antibiotic Resistance Sales Forecast by Type (2022-2027)
4.2.2 Global Antibiotic Resistance Revenue Forecast by Type (2022-2027)
4.2.3 Global Antibiotic Resistance Price Forecast by Type (2022-2027)
5 Global Antibiotic Resistance Market Size by Application
5.1 Global Antibiotic Resistance Historic Market Review by Application (2016-2021)
5.1.1 Global Antibiotic Resistance Sales Market Share by Application (2016-2021)
5.1.2 Global Antibiotic Resistance Revenue Market Share by Application (2016-2021)
5.1.3 Global Antibiotic Resistance Price by Application (2016-2021)
5.2 Global Antibiotic Resistance Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Antibiotic Resistance Sales Forecast by Application (2022-2027)
5.2.2 Global Antibiotic Resistance Revenue Forecast by Application (2022-2027)
5.2.3 Global Antibiotic Resistance Price Forecast by Application (2022-2027)
6 North America Antibiotic Resistance Market Facts & Figures
6.1 North America Antibiotic Resistance Sales by Company
6.1.1 North America Antibiotic Resistance Sales by Company (2016-2021)
6.1.2 North America Antibiotic Resistance Revenue by Company (2016-2021)
6.2 North America Antibiotic Resistance Sales Breakdown by Type
6.2.1 North America Antibiotic Resistance Sales Breakdown by Type (2016-2021)
6.2.2 North America Antibiotic Resistance Sales Breakdown by Type (2022-2027)
6.3 North America Antibiotic Resistance Sales Breakdown by Application
6.3.1 North America Antibiotic Resistance Sales Breakdown by Application (2016-2021)
6.3.2 North America Antibiotic Resistance Sales Breakdown by Application (2022-2027)
7 Europe Antibiotic Resistance Market Facts & Figures
7.1 Europe Antibiotic Resistance Sales by Company
7.1.1 Europe Antibiotic Resistance Sales by Company (2016-2021)
7.1.2 Europe Antibiotic Resistance Revenue by Company (2016-2021)
7.2 Europe Antibiotic Resistance Sales Breakdown by Type
7.2.1 Europe Antibiotic Resistance Sales Breakdown by Type (2016-2021)
7.2.2 Europe Antibiotic Resistance Sales Breakdown by Type (2022-2027)
7.3 Europe Antibiotic Resistance Sales Breakdown by Application
7.3.1 Europe 146 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 146 Sales Breakdown by Application (2022-2027)
8 China Antibiotic Resistance Market Facts & Figures
8.1 China Antibiotic Resistance Sales by Company
8.1.1 China Antibiotic Resistance Sales by Company (2016-2021)
8.1.2 China Antibiotic Resistance Revenue by Company (2016-2021)
8.2 China Antibiotic Resistance Sales Breakdown by Type
8.2.1 China Antibiotic Resistance Sales Breakdown by Type (2016-2021)
8.2.2 China Antibiotic Resistance Sales Breakdown by Type (2022-2027)
8.3 China Antibiotic Resistance Sales Breakdown by Application
8.3.1 China 313 Sales Breakdown by Application (2016-2021)
8.3.2 China 313 Sales Breakdown by Application (2022-2027)
9 Japan Antibiotic Resistance Market Facts & Figures
9.1 Japan Antibiotic Resistance Sales by Company
9.1.1 Japan Antibiotic Resistance Sales by Company (2016-2021)
9.1.2 Japan Antibiotic Resistance Revenue by Company (2016-2021)
9.2 Japan Antibiotic Resistance Sales Breakdown by Type
9.2.1 Japan Antibiotic Resistance Sales Breakdown by Type (2016-2021)
9.2.2 Japan Antibiotic Resistance Sales Breakdown by Type (2022-2027)
9.3 Japan Antibiotic Resistance Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Antibiotic Resistance Market Facts & Figures
10.1 Southeast Asia Antibiotic Resistance Sales by Company
10.1.1 Southeast Asia Antibiotic Resistance Sales by Company (2016-2021)
10.1.2 Southeast Asia Antibiotic Resistance Revenue by Company (2016-2021)
10.2 Southeast Asia Antibiotic Resistance Sales Breakdown by Type
10.2.1 Southeast Asia Antibiotic Resistance Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Antibiotic Resistance Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Antibiotic Resistance Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)
11 India Antibiotic Resistance Market Facts & Figures
11.1 India Antibiotic Resistance Sales by Company
11.1.1 India Antibiotic Resistance Sales by Company (2016-2021)
11.1.2 India Antibiotic Resistance Revenue by Company (2016-2021)
11.2 India Antibiotic Resistance Sales Breakdown by Type
11.2.1 India Antibiotic Resistance Sales Breakdown by Type (2016-2021)
11.2.2 India Antibiotic Resistance Sales Breakdown by Type (2022-2027)
11.3 India Antibiotic Resistance Sales Breakdown by Application
11.3.1 India Antibiotic Resistance Sales Breakdown by Application (2016-2021)
11.3.2 India Antibiotic Resistance Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Antibiotic Resistance Business
12.1 Allergan
12.1.1 Allergan Corporation Information
12.1.2 Allergan Business Overview
12.1.3 Allergan Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Allergan Antibiotic Resistance Products Offered
12.1.5 Allergan Recent Development
12.2 AmpliPhi Biosciences
12.2.1 AmpliPhi Biosciences Corporation Information
12.2.2 AmpliPhi Biosciences Business Overview
12.2.3 AmpliPhi Biosciences Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
12.2.4 AmpliPhi Biosciences Antibiotic Resistance Products Offered
12.2.5 AmpliPhi Biosciences Recent Development
12.3 BioVersys GmbH
12.3.1 BioVersys GmbH Corporation Information
12.3.2 BioVersys GmbH Business Overview
12.3.3 BioVersys GmbH Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
12.3.4 BioVersys GmbH Antibiotic Resistance Products Offered
12.3.5 BioVersys GmbH Recent Development
12.4 Macrolide Pharmaceuticals
12.4.1 Macrolide Pharmaceuticals Corporation Information
12.4.2 Macrolide Pharmaceuticals Business Overview
12.4.3 Macrolide Pharmaceuticals Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Macrolide Pharmaceuticals Antibiotic Resistance Products Offered
12.4.5 Macrolide Pharmaceuticals Recent Development
12.5 Melinta Therapeutics
12.5.1 Melinta Therapeutics Corporation Information
12.5.2 Melinta Therapeutics Business Overview
12.5.3 Melinta Therapeutics Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Melinta Therapeutics Antibiotic Resistance Products Offered
12.5.5 Melinta Therapeutics Recent Development
12.6 Merck
12.6.1 Merck Corporation Information
12.6.2 Merck Business Overview
12.6.3 Merck Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Merck Antibiotic Resistance Products Offered
12.6.5 Merck Recent Development
12.7 Nabriva Therapeutics
12.7.1 Nabriva Therapeutics Corporation Information
12.7.2 Nabriva Therapeutics Business Overview
12.7.3 Nabriva Therapeutics Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Nabriva Therapeutics Antibiotic Resistance Products Offered
12.7.5 Nabriva Therapeutics Recent Development
12.8 Nemesis Bioscience
12.8.1 Nemesis Bioscience Corporation Information
12.8.2 Nemesis Bioscience Business Overview
12.8.3 Nemesis Bioscience Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Nemesis Bioscience Antibiotic Resistance Products Offered
12.8.5 Nemesis Bioscience Recent Development
12.9 Phage Technologies S.A
12.9.1 Phage Technologies S.A Corporation Information
12.9.2 Phage Technologies S.A Business Overview
12.9.3 Phage Technologies S.A Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Phage Technologies S.A Antibiotic Resistance Products Offered
12.9.5 Phage Technologies S.A Recent Development
12.10 Tetraphase Pharmaceuticals
12.10.1 Tetraphase Pharmaceuticals Corporation Information
12.10.2 Tetraphase Pharmaceuticals Business Overview
12.10.3 Tetraphase Pharmaceuticals Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Tetraphase Pharmaceuticals Antibiotic Resistance Products Offered
12.10.5 Tetraphase Pharmaceuticals Recent Development
12.11 The Medicines Company
12.11.1 The Medicines Company Corporation Information
12.11.2 The Medicines Company Business Overview
12.11.3 The Medicines Company Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
12.11.4 The Medicines Company Antibiotic Resistance Products Offered
12.11.5 The Medicines Company Recent Development
12.12 TPfizer
12.12.1 TPfizer Corporation Information
12.12.2 TPfizer Business Overview
12.12.3 TPfizer Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
12.12.4 TPfizer Antibiotic Resistance Products Offered
12.12.5 TPfizer Recent Development
12.13 Westway Health
12.13.1 Westway Health Corporation Information
12.13.2 Westway Health Business Overview
12.13.3 Westway Health Antibiotic Resistance Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Westway Health Antibiotic Resistance Products Offered
12.13.5 Westway Health Recent Development
13 Antibiotic Resistance Manufacturing Cost Analysis
13.1 Antibiotic Resistance Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Antibiotic Resistance
13.4 Antibiotic Resistance Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Antibiotic Resistance Distributors List
14.3 Antibiotic Resistance Customers
15 Market Dynamics
15.1 Antibiotic Resistance Market Trends
15.2 Antibiotic Resistance Drivers
15.3 Antibiotic Resistance Market Challenges
15.4 Antibiotic Resistance Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
    Table 1. Global Antibiotic Resistance Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
    Table 2. Global Antibiotic Resistance Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
    Table 3. Global Antibiotic Resistance Market Size (US$ Million) by Region: 2016 VS 2021 &2027
    Table 4. Global Antibiotic Resistance Sales (K Pcs) by Region (2016-2021)
    Table 5. Global Antibiotic Resistance Sales Market Share by Region (2016-2021)
    Table 6. Global Antibiotic Resistance Revenue (US$ Million) Market Share by Region (2016-2021))
    Table 7. Global Antibiotic Resistance Revenue Share by Region (2016-2021)
    Table 8. Global Antibiotic Resistance Sales (K Pcs) Forecast by Region (2022-2027)
    Table 9. Global Antibiotic Resistance Sales Market Share Forecast by Region (2022-2027)
    Table 10. Global Antibiotic Resistance Revenue (US$ Million) Forecast by Region (2022-2027)
    Table 11. Global Antibiotic Resistance Revenue Share Forecast by Region (2022-2027)
    Table 12. Global Antibiotic Resistance Sales (K Pcs) of Key Companies (2016-2021)
    Table 13. Global Antibiotic Resistance Sales Share by Company (2016-2021)
    Table 14. Global Antibiotic Resistance Revenue (US$ Million) by Company (2016-2021)
    Table 15. Global Antibiotic Resistance Revenue Share by Company (2016-2021)
    Table 16. Global Antibiotic Resistance by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibiotic Resistance as of 2020)
    Table 17. Global Antibiotic Resistance Average Price (USD/Pcs) of Key Company (2016-2021)
    Table 18. Manufacturers Antibiotic Resistance Manufacturing Sites and Area Served
    Table 19. Manufacturers Antibiotic Resistance Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global Antibiotic Resistance Sales (K Pcs) by Type (2016-2021)
    Table 22. Global Antibiotic Resistance Sales Share by Type (2016-2021)
    Table 23. Global Antibiotic Resistance Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 24. Global Antibiotic Resistance Price (USD/Pcs) by Type (2016-2021)
    Table 25. Global Antibiotic Resistance Sales Share by Type (2022-2027)
    Table 26. Global Antibiotic Resistance Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 27. Global Antibiotic Resistance Revenue Share by Type (2022-2027)
    Table 28. Global Antibiotic Resistance Price (USD/Pcs) by Type (2022-2027)
    Table 29. Global Antibiotic Resistance Sales (K Pcs) by Application (2016-2021)
    Table 30. Global Antibiotic Resistance Sales Share by Application (2016-2021)
    Table 31. Global Antibiotic Resistance Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 32. Global Antibiotic Resistance Price (USD/Pcs) by Application (2016-2021)
    Table 33. Global Antibiotic Resistance Sales (K Pcs) by Application (2022-2027)
    Table 34. Global Antibiotic Resistance Sales Share by Application (2022-2027)
    Table 35. Global Antibiotic Resistance Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 36. Global Antibiotic Resistance Revenue Share by Application (2022-2027)
    Table 37. Global Antibiotic Resistance Price (USD/Pcs) by Application (2022-2027)
    Table 38. North America Antibiotic Resistance Sales (K Pcs) by Company (2016-2021)
    Table 39. North America Antibiotic Resistance Sales Market Share by Company (2016-2021)
    Table 40. North America Antibiotic Resistance Revenue by Company (2016-2021) & (US$ Million)
    Table 41. North America Antibiotic Resistance Revenue Market Share by Company (2016-2021)
    Table 42. North America Antibiotic Resistance Sales by Type (2016-2021) & (K Pcs)
    Table 43. North America Antibiotic Resistance Sales Market Share by Type (2016-2021)
    Table 44. North America Antibiotic Resistance Sales by Type (2022-2027) & (K Pcs)
    Table 45. North America Antibiotic Resistance Sales Market Share by Type (2022-2027)
    Table 46. North America Antibiotic Resistance Sales by Application (2016-2021) & (K Pcs)
    Table 47. North America Antibiotic Resistance Sales Market Share by Application (2016-2021)
    Table 48. North America Antibiotic Resistance Sales by Application (2022-2027) & (K Pcs)
    Table 49. North America Antibiotic Resistance Sales Market Share by Application (2022-2027)
    Table 50. Europe Antibiotic Resistance Sales (K Pcs) by Company (2016-2021)
    Table 51. Europe Antibiotic Resistance Sales Market Share by Company (2016-2021)
    Table 52. Europe Antibiotic Resistance Revenue by Company (2016-2021) & (US$ Million)
    Table 53. Europe Antibiotic Resistance Revenue Market Share by Company (2016-2021)
    Table 54. Europe Antibiotic Resistance Sales by Type (2016-2021) & (K Pcs)
    Table 55. Europe Antibiotic Resistance Sales Market Share by Type (2016-2021)
    Table 56. Europe Antibiotic Resistance Sales by Type (2022-2027) & (K Pcs)
    Table 57. Europe Antibiotic Resistance Sales Market Share by Type (2022-2027)
    Table 58. Europe Antibiotic Resistance Sales by Application (2016-2021) & (K Pcs)
    Table 59. Europe Antibiotic Resistance Sales Market Share by Application (2016-2021)
    Table 60. Europe Antibiotic Resistance Sales by Application (2022-2027) & (K Pcs)
    Table 61. Europe Antibiotic Resistance Sales Market Share by Application (2022-2027)
    Table 62. China Antibiotic Resistance Sales (K Pcs) by Company (2016-2021)
    Table 63. China Antibiotic Resistance Sales Market Share by Company (2016-2021)
    Table 64. China Antibiotic Resistance Revenue by Company (2016-2021) & (US$ Million)
    Table 65. China Antibiotic Resistance Revenue Market Share by Company (2016-2021)
    Table 66. China Antibiotic Resistance Sales by Type (2016-2021) & (K Pcs)
    Table 67. China Antibiotic Resistance Sales Market Share by Type (2016-2021)
    Table 68. China Antibiotic Resistance Sales by Type (2022-2027) & (K Pcs)
    Table 69. China Antibiotic Resistance Sales Market Share by Type (2022-2027)
    Table 70. China Antibiotic Resistance Sales by Application (2016-2021) & (K Pcs)
    Table 71. China Antibiotic Resistance Sales Market Share by Application (2016-2021)
    Table 72. China Antibiotic Resistance Sales by Application (2022-2027) & (K Pcs)
    Table 73. China Antibiotic Resistance Sales Market Share by Application (2022-2027)
    Table 74. Japan Antibiotic Resistance Sales (K Pcs) by Company (2016-2021)
    Table 75. Japan Antibiotic Resistance Sales Market Share by Company (2016-2021)
    Table 76. Japan Antibiotic Resistance Revenue by Company (2016-2021) & (US$ Million)
    Table 77. Japan Antibiotic Resistance Revenue Market Share by Company (2016-2021)
    Table 78. Japan Antibiotic Resistance Sales by Type (2016-2021) & (K Pcs)
    Table 79. Japan Antibiotic Resistance Sales Market Share by Type (2016-2021)
    Table 80. Japan Antibiotic Resistance Sales by Type (2022-2027) & (K Pcs)
    Table 81. Japan Antibiotic Resistance Sales Market Share by Type (2022-2027)
    Table 82. Japan Antibiotic Resistance Sales by Application (2016-2021) & (K Pcs)
    Table 83. Japan Antibiotic Resistance Sales Market Share by Application (2016-2021)
    Table 84. Japan Antibiotic Resistance Sales by Application (2022-2027) & (K Pcs)
    Table 85. Japan Antibiotic Resistance Sales Market Share by Application (2022-2027)
    Table 86. Southeast Asia Antibiotic Resistance Sales (K Pcs) by Company (2016-2021)
    Table 87. Southeast Asia Antibiotic Resistance Sales Market Share by Company (2016-2021)
    Table 88. Southeast Asia Antibiotic Resistance Revenue by Company (2016-2021) & (US$ Million)
    Table 89. Southeast Asia Antibiotic Resistance Revenue Market Share by Company (2016-2021)
    Table 90. Southeast Asia Antibiotic Resistance Sales by Type (2016-2021) & (K Pcs)
    Table 91. Southeast Asia Antibiotic Resistance Sales Market Share by Type (2016-2021)
    Table 92. Southeast Asia Antibiotic Resistance Sales by Type (2022-2027) & (K Pcs)
    Table 93. Southeast Asia Antibiotic Resistance Sales Market Share by Type (2022-2027)
    Table 94. Southeast Asia Antibiotic Resistance Sales by Application (2016-2021) & (K Pcs)
    Table 95. Southeast Asia Antibiotic Resistance Sales Market Share by Application (2016-2021)
    Table 96. Southeast Asia Antibiotic Resistance Sales by Application (2022-2027) & (K Pcs)
    Table 97. Southeast Asia Antibiotic Resistance Sales Market Share by Application (2022-2027)
    Table 98. India Antibiotic Resistance Sales (K Pcs) by Company (2016-2021)
    Table 99. India Antibiotic Resistance Sales Market Share by Company (2016-2021)
    Table 100. India Antibiotic Resistance Revenue by Company (2016-2021) & (US$ Million)
    Table 101. India Antibiotic Resistance Revenue Market Share by Company (2016-2021)
    Table 102. India Antibiotic Resistance Sales by Type (2016-2021) & (K Pcs)
    Table 103. India Antibiotic Resistance Sales Market Share by Type (2016-2021)
    Table 104. India Antibiotic Resistance Sales by Type (2022-2027) & (K Pcs)
    Table 105. India Antibiotic Resistance Sales Market Share by Type (2022-2027)
    Table 106. India Antibiotic Resistance Sales by Application (2016-2021) & (K Pcs)
    Table 107. India Antibiotic Resistance Sales Market Share by Application (2016-2021)
    Table 108. India Antibiotic Resistance Sales by Application (2022-2027) & (K Pcs)
    Table 109. India Antibiotic Resistance Sales Market Share by Application (2022-2027)
    Table 110. Allergan Corporation Information
    Table 111. Allergan Description and Business Overview
    Table 112. Allergan Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 113. Allergan Antibiotic Resistance Product
    Table 114. Allergan Recent Development
    Table 115. AmpliPhi Biosciences Corporation Information
    Table 116. AmpliPhi Biosciences Description and Business Overview
    Table 117. AmpliPhi Biosciences Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 118. AmpliPhi Biosciences Antibiotic Resistance Product
    Table 119. AmpliPhi Biosciences Recent Development
    Table 120. BioVersys GmbH Corporation Information
    Table 121. BioVersys GmbH Description and Business Overview
    Table 122. BioVersys GmbH Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 123. BioVersys GmbH Antibiotic Resistance Product
    Table 124. BioVersys GmbH Recent Development
    Table 125. Macrolide Pharmaceuticals Corporation Information
    Table 126. Macrolide Pharmaceuticals Description and Business Overview
    Table 127. Macrolide Pharmaceuticals Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 128. Macrolide Pharmaceuticals Antibiotic Resistance Product
    Table 129. Macrolide Pharmaceuticals Recent Development
    Table 130. Melinta Therapeutics Corporation Information
    Table 131. Melinta Therapeutics Description and Business Overview
    Table 132. Melinta Therapeutics Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 133. Melinta Therapeutics Antibiotic Resistance Product
    Table 134. Melinta Therapeutics Recent Development
    Table 135. Merck Corporation Information
    Table 136. Merck Description and Business Overview
    Table 137. Merck Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 138. Merck Antibiotic Resistance Product
    Table 139. Merck Recent Development
    Table 140. Nabriva Therapeutics Corporation Information
    Table 141. Nabriva Therapeutics Description and Business Overview
    Table 142. Nabriva Therapeutics Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 143. Nabriva Therapeutics Antibiotic Resistance Product
    Table 144. Nabriva Therapeutics Recent Development
    Table 145. Nemesis Bioscience Corporation Information
    Table 146. Nemesis Bioscience Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 147. Nemesis Bioscience Description and Business Overview
    Table 148. Nemesis Bioscience Antibiotic Resistance Product
    Table 149. Nemesis Bioscience Recent Development
    Table 150. Phage Technologies S.A Corporation Information
    Table 151. Phage Technologies S.A Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 152. Phage Technologies S.A Description and Business Overview
    Table 153. Phage Technologies S.A Antibiotic Resistance Product
    Table 154. Phage Technologies S.A Recent Development
    Table 155. Tetraphase Pharmaceuticals Corporation Information
    Table 156. Tetraphase Pharmaceuticals Description and Business Overview
    Table 157. Tetraphase Pharmaceuticals Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 158. Tetraphase Pharmaceuticals Antibiotic Resistance Product
    Table 159. Tetraphase Pharmaceuticals Recent Development
    Table 160. The Medicines Company Corporation Information
    Table 161. The Medicines Company Description and Business Overview
    Table 162. The Medicines Company Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 163. The Medicines Company Antibiotic Resistance Product
    Table 164. The Medicines Company Recent Development
    Table 165. TPfizer Corporation Information
    Table 166. TPfizer Description and Business Overview
    Table 167. TPfizer Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 168. TPfizer Antibiotic Resistance Product
    Table 169. TPfizer Recent Development
    Table 170. Westway Health Corporation Information
    Table 171. Westway Health Description and Business Overview
    Table 172. Westway Health Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 173. Westway Health Antibiotic Resistance Product
    Table 174. Westway Health Recent Development
    Table 175. Production Base and Market Concentration Rate of Raw Material
    Table 176. Key Suppliers of Raw Materials
    Table 177. Antibiotic Resistance Distributors List
    Table 178. Antibiotic Resistance Customers List
    Table 179. Antibiotic Resistance Market Trends
    Table 180. Antibiotic Resistance Market Drivers
    Table 181. Antibiotic Resistance Market Challenges
    Table 182. Antibiotic Resistance Market Restraints
    Table 183. Research Programs/Design for This Report
    Table 184. Key Data Information from Secondary Sources
    Table 185. Key Data Information from Primary Sources
List of Figures
    Figure 1. Antibiotic Resistance Product Picture
    Figure 2. Global Antibiotic Resistance Sales Market Share by Type in 2021 & 2027
    Figure 3. Type I Product Picture
    Figure 4. Type II Product Picture
    Figure 5. Global Antibiotic Resistance Sales Market Share by Application in 2021 & 2027
    Figure 6. Oxazolidinones Examples
    Figure 7. Lipoglycopeptides Examples
    Figure 8. Tetracyclines Examples
    Figure 9. Cephalosporins Examples
    Figure 10. Combination therapies Examples
    Figure 11. Other Examples
    Figure 12. Global Antibiotic Resistance Sales, (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Antibiotic Resistance Sales Growth Rate (2016-2027) & (US$ Million)
    Figure 14. Global Antibiotic Resistance Sales (K Pcs) Growth Rate (2016-2027)
    Figure 15. Global Antibiotic Resistance Price Trends Growth Rate (2016-2027) (USD/Pcs)
    Figure 16. Global Antibiotic Resistance Revenue Market Share by Region: 2016 VS 2021
    Figure 17. Global Antibiotic Resistance Revenue Market Share by Region: 2021 VS 2027
    Figure 18. North America Antibiotic Resistance Revenue (Million USD) Growth Rate (2016-2027)
    Figure 19. North America Antibiotic Resistance Sales (K Pcs) Growth Rate (2016-2027)
    Figure 20. Europe Antibiotic Resistance Revenue (Million USD) Growth Rate (2016-2027)
    Figure 21. Europe Antibiotic Resistance Sales (Million USD) Growth Rate (2016-2027)
    Figure 22. China Antibiotic Resistance Revenue (Million USD) Growth Rate (2016-2027)
    Figure 23. China Antibiotic Resistance Sales (Million USD) and Growth Rate (2016-2027)
    Figure 24. Japan Antibiotic Resistance Revenue (Million USD) Growth Rate (2016-2027)
    Figure 25. Japan Antibiotic Resistance Sales (Million USD) Growth Rate (2016-2027)
    Figure 26. Southeast Asia Antibiotic Resistance Revenue (Million USD) Growth Rate (2016-2027)
    Figure 27. Southeast Asia Antibiotic Resistance Sales (Million USD) Growth Rate (2016-2027)
    Figure 28. India Antibiotic Resistance Revenue (Million USD) Growth Rate (2016-2027)
    Figure 29. India Antibiotic Resistance Sales (Million USD) Growth Rate (2016-2027)
    Figure 30. Global 5 Largest Antibiotic Resistance Players Market Share by Revenue in Antibiotic Resistance: 2016 & 2020
    Figure 31. Antibiotic Resistance Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 32. Global Antibiotic Resistance Revenue Share by Type (2016-2021)
    Figure 33. Global Antibiotic Resistance Revenue Growth Rate by Type in 2016 & 2020
    Figure 34. Global Antibiotic Resistance Revenue Share by Application (2016-2021)
    Figure 35. Global Antibiotic Resistance Revenue Growth Rate by Application in 2016 & 2020
    Figure 36. North America Antibiotic Resistance Sales Market Share by Type in 2020
    Figure 37. North America Antibiotic Resistance Sales Market Share by Application in 2020
    Figure 38. Europe Antibiotic Resistance Sales Market Share by Type in 2020
    Figure 39. Europe Antibiotic Resistance Sales Market Share by Application in 2020
    Figure 40. China Antibiotic Resistance Sales Market Share by Type in 2020
    Figure 41. China Antibiotic Resistance Sales Market Share by Application in 2020
    Figure 42. Japan Antibiotic Resistance Sales Market Share by Type in 2020
    Figure 43. Japan Antibiotic Resistance Sales Market Share by Application in 2020
    Figure 44. Southeast Asia Antibiotic Resistance Sales Market Share by Type in 2020
    Figure 45. Southeast Asia Antibiotic Resistance Sales Market Share by Application in 2020
    Figure 46. India Antibiotic Resistance Sales Market Share by Type in 2020
    Figure 47. India Antibiotic Resistance Sales Market Share by Application in 2020
    Figure 48. Key Raw Materials Price Trend
    Figure 49. Manufacturing Cost Structure of Antibiotic Resistance
    Figure 50. Manufacturing Process Analysis of Antibiotic Resistance
    Figure 51. Antibiotic Resistance Industrial Chain Analysis
    Figure 52. Channels of Distribution
    Figure 53. Distributors Profiles
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4000
This license allows only one user to access the PDF.

Electronic (PDF)
$6000
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$8000
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Samsung SD

RELATED REPORTS

Global and United States Sexually Transmitted Disease Therapeutics Market Report Forecast 2022 2028
Global and United States Sexually Transmitted Disease Therapeutics Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Othe-412
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Vaccine Technologies Market Report Forecast 2022 2028
Global and United States Vaccine Technologies Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-30Z5715
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Healthcare Acquired Infection Market Report Forecast 2022 2028
Global and United States Healthcare-Acquired Infection Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-24Z5686
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Viral Vector Vaccines Market Report Forecast 2022 2028
Global and United States Viral Vector Vaccines Market Report & Forecast 2022-2028

Viral vector vaccines combine many of the positive qualities of DNA vaccines with those of live attenuated vaccines.Market Analysis and Insights Global and United States Viral Vector Vaccines MarketThis report focuses on global and United States Viral Vector Vaccines market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Viral Vector Vaccines market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-30G10233
Tue Jun 07 00:00:00 UTC 2022

Add to Cart